Business Context and Reporting Period
Codexis, Inc. filed a Form 8-K Current Report on May 16, 2011, regarding a material definitive agreement entered into on that date.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a contractual agreement.
Material Changes
On May 16, 2011, Codexis, Inc. entered into a Manufacture and Supply Agreement with Lactosan GmbH & Co. KG. Under this agreement, Lactosan agreed to manufacture and supply certain of Codexis's proprietary enzymes to the Company and its customers based on forecasts provided by Codexis.
Agreement Terms and Outlook
- Term: The agreement has an initial three-year term with provisions for one-year renewals under certain circumstances.
- Provisions: The agreement includes customary representations, warranties, covenants, and indemnification clauses for losses arising from breaches.
- Documentation: The full text of the agreement is scheduled to be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2011.
Investor Verification Points
- Review the full Manufacture and Supply Agreement when filed as an exhibit to the Form 10-Q for the quarter ending June 30, 2011.
- Verify the specific enzymes covered under the agreement and the forecast mechanisms required.
- Monitor future filings for any financial impact or revenue recognition related to this supply arrangement.